Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
Launched by JOHNS HOPKINS UNIVERSITY · Jul 26, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach called the "PICU Up!" intervention, which aims to help critically ill children recover more effectively while they are in the Pediatric Intensive Care Unit (PICU). The focus is on encouraging early movement and activity for children who are on mechanical ventilation (a machine that helps them breathe) for at least 48 hours. This trial is important because many children who survive critical illnesses end up with long-lasting issues, and early mobility may help reduce these problems.
To participate in this study, children must be on mechanical ventilation for 48 hours by the third day of their PICU stay. However, those who are expected to have life support removed soon, have open surgeries, or are on certain life-saving machines are not eligible. If enrolled, participants will receive the PICU Up! intervention, which includes support for movement, managing sedation (medications that help with sleep), and preventing confusion, all tailored to their needs. This trial is taking place in several hospitals across the United States, and if successful, it could significantly improve care for children in critical condition and enhance their recovery outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Invasive mechanical ventilation via oral or nasal endotracheal tube ≥ 48 hours at 7 a.m. on PICU Day 3
- Exclusion Criteria:
- • Active or anticipated withdrawal of life support within 48 hours
- • Open chest or open abdomen
- • Current use of Extracorporeal Membrane Oxygenation (ECMO)
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Madera, California, United States
Orlando, Florida, United States
Louisville, Kentucky, United States
Minneapolis, Minnesota, United States
Lebanon, New Hampshire, United States
Chapel Hill, North Carolina, United States
Danville, Pennsylvania, United States
Houston, Texas, United States
Morgantown, West Virginia, United States
Milwaukee, Wisconsin, United States
Patients applied
Trial Officials
Sapna Kudchadkar, MD, PhD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials